Colgate (NYSE: CL) director defers retainer into 266 stock units

Rhea-AI Filing Summary

Colgate-Palmolive director John P. Bilbrey acquired 266 shares of Common Stock as a compensation award. The shares, valued at $89.05 each, represent a portion of his annual cash retainer that was deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors.

After this grant, he directly holds 37,665 Colgate-Palmolive shares and has an additional 4,719 shares held indirectly by a trust. The transaction reflects routine director compensation rather than an open-market purchase.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider BILBREY JOHN P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	266	$89.05	$24K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 37,665 shares (Direct); Common Stock — 4,719 shares (Indirect, By Trust)

Footnotes (1)

1. [object Object]

Key Figures

Director stock grant: 266 shares Grant reference price: $89.05 per share Direct holdings after grant: 37,665 shares +1 more

4 metrics

Director stock grant 266 shares Compensation award on 2026-04-01

Grant reference price $89.05 per share Value used for 266-share award

Direct holdings after grant 37,665 shares John P. Bilbrey direct Colgate-Palmolive shares

Indirect holdings after grant 4,719 shares Held indirectly by trust

Key Terms

Deferred Compensation Plan for Non-Employee Directors, annual cash retainer, stock unit account

3 terms

Deferred Compensation Plan for Non-Employee Directors financial

"deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors"

annual cash retainer financial

"Portion of annual cash retainer deferred to a stock unit account"

stock unit account financial

"deferred to a stock unit account pursuant to the Deferred Compensation Plan"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BILBREY JOHN P

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		266	A	$89.05	37,665	D
Common Stock								4,719	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

	/s/ Kristine Hutchinson, Attorney-in-Fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Colgate-Palmolive (CL) director John P. Bilbrey report in this Form 4?

John P. Bilbrey reported acquiring 266 shares of Colgate-Palmolive Common Stock as a compensation grant. The award reflects a portion of his annual cash retainer deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors.

Was John P. Bilbrey’s Colgate-Palmolive (CL) transaction an open-market stock purchase?

No, the 266-share transaction was a grant or award, not an open-market purchase. It represents deferred director compensation credited to a stock unit account, rather than shares bought by Bilbrey in the public market on his own initiative.

How many Colgate-Palmolive (CL) shares does John P. Bilbrey hold after this grant?

After the grant, John P. Bilbrey holds 37,665 shares of Colgate-Palmolive Common Stock directly. He also has 4,719 shares held indirectly through a trust, giving a combined reported position across direct and indirect holdings in the company.

What is the value per share of John P. Bilbrey’s Colgate-Palmolive compensation award?

The 266-share compensation award is recorded at $89.05 per share. This per-share figure is used for reporting the value of the portion of his annual cash retainer that was deferred into Colgate-Palmolive stock units for non-employee directors.

What is Colgate-Palmolive’s Deferred Compensation Plan for Non-Employee Directors?

It is a plan allowing non-employee directors to defer portions of their annual cash retainers into a stock unit account. In this case, John P. Bilbrey deferred part of his retainer, receiving 266 Colgate-Palmolive stock units instead of immediate cash payment.